Cesium carbonate → Methyl 1-(1-cyclopropyl-6-{[6-(1-methyl-1H-pyrazol-4-yl)-4-oxospiro[chroman-2,4'-piperidin]-1'-yl]carbonyl}-1H-indol-4-yl)piperidine-4-carboxylate

HRID 38466Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 38466
C([O-])([O-])=O.[Cs+].[Cs+].FC(F)(F)S(O[C:13]1[CH:21]=[C:20]([C:22]([N:24]2[CH2:29][CH2:28][C:27]3([CH2:38][C:37](=[O:39])[C:36]4[C:31](=[CH:32][CH:33]=[C:34]([C:40]5[CH:41]=[N:42][N:43]([CH3:45])[CH:44]=5)[CH:35]=4)[O:30]3)[CH2:26][CH2:25]2)=[O:23])[CH:19]=[C:18]2[C:14]=1[CH:15]=[CH:16][N:17]2[CH:46]1[CH2:48][CH2:47]1)(=O)=O.[NH:51]1[CH2:56][CH2:55][CH:54]([C:57]([O:59][CH2:60]C)=[O:58])[CH2:53][CH2:52]1.C1(C2C=CC=CC=2)C=CC=CC=1P(C(C)(C)C)C(C)(C)C>O1CCOCC1.CC([O-])=O.CC([O-])=O.[Pd+2]>[CH:46]1([N:17]2[C:18]3[C:14](=[C:13]([N:51]4[CH2:56][CH2:55][CH:54]([C:57]([O:59][CH3:60])=[O:58])[CH2:53][CH2:52]4)[CH:21]=[C:20]([C:22]([N:24]4[CH2:25][CH2:26][C:27]5([CH2:38][C:37](=[O:39])[C:36]6[C:31](=[CH:32][CH:33]=[C:34]([C:40]7[CH:41]=[N:42][N:43]([CH3:45])[CH:44]=7)[CH:35]=6)[O:30]5)[CH2:28][CH2:29]4)=[O:23])[CH:19]=3)[CH:15]=[CH:16]2)[CH2:47][CH2:48]1

Komponenten

7

Edukt 4

HCID 10796Cesium carbonateHCID 70770Ethyl 4-piperidinecarboxylateHCID 27342152-(Di-tert-butylphosphino)biphenylHCID 582087121-cyclopropyl-6-{[6-(1-methyl-1H-pyrazol-4-yl)-4-oxospiro[chroman-2,4'-piperidin]-1'-yl]carbonyl}-1H-indol-4-yl trifluoromethanesulfonate

Produkt 1

HCID 67055541Methyl 1-(1-cyclopropyl-6-{[6-(1-methyl-1H-pyrazol-4-yl)-4-oxospiro[chroman-2,4'-piperidin]-1'-yl]carbonyl}-1H-indol-4-yl)piperidine-4-carboxylate

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 167845palladium(II) acetateKatalysatorHCID 312751,4-DioxaneLösungsmittel

Reaktionsbedingungen

Temperatur
100 °C

Versuchsvorschrift

Cs2CO3 (261 mg, 0.800 mmol), Pd(OAc)2 (8.98 mg, 0.040 mmol), 1-cyclopropyl-6-{[6-(1-methyl-1H-pyrazol-4-yl)-4-oxospiro[chroman-2,4′-piperidin]-1′-yl]carbonyl}-1H-indol-4-yl trifluoromethanesulfonate (251 mg, 0.4 mmol), ethyl 4-piperidinecarboxylate (94.0 mg, 0.600 mmol) and biphenyl-2-yl(di-tert-butyl)phosphine (11.9 mg, 0.0400 mmol) were suspended in 1,4-dioxane (3 ml) and the mixture was stirred at 100° C. overnight. The mixture was filtered through celite pad, washing with CHCl3, and the solvent was evaporated under reduced pressure. The residue was purified by silicagel column chromatography (CHCl3/MeOH), then preparative-TLC (CHCl3/MeOH) to give intended compound as brown oil.

Aufarbeitung

  1. filtrationThe mixture was filtered through celite pad
  2. washwashing with CHCl3
  3. customthe solvent was evaporated under reduced pressure
  4. customThe residue was purified by silicagel column chromatography (CHCl3/MeOH)
  5. custompreparative-TLC (CHCl3/MeOH) to give

Quellen und Nachweise

ORD-Eintrag
ord-2e513f059c534c47bb77afa38ccd88a4
Quelldatensatz
uspto-grants-2013_09
Patentnummer
US08524730B2

Notizen zur Reaktion

Wird geladen…